Global Alpha-1 Antitrypsin Drugs Market Trajectory & Analytics Report 2021: Market to Reach $2 Billion by 2027 – U.S. Market is Estimated at $319.3 Million, While China is Forecast to Grow at 9% CAGR – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Alpha-1 Antitrypsin Drugs – Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering.
Global Alpha-1 Antitrypsin Drugs Market to Reach $2 Billion by 2027
Amid the COVID-19 crisis, the global market for Alpha-1 Antitrypsin Drugs estimated at US$1.1 Billion in the year 2020, is projected to reach a revised size of US$2 Billion by 2027, growing at a CAGR of 9.6% over the period 2020-2027.
The U.S. Market is Estimated at $319.3 Million, While China is Forecast to Grow at 9% CAGR
The Alpha-1 Antitrypsin Drugs market in the U.S. is estimated at US$319.3 Million in the year 2020. China, the world’s second largest economy, is forecast to reach a projected market size of US$354.1 Million by the year 2027 trailing a CAGR of 9% over the analysis period 2020 to 2027.
Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 8.9% and 7.8% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 7.8% CAGR.
(Total 43 Featured):
- Abeona Therapeutics
- Alnylam Pharmaceuticals
- Applied Genetic Technologies Corp
- Arrowhead Research Corporation
- Baxalta
- Baxter
- CSL Behring
- Grifols
- Kamada
- Shire
- Takeda Pharmaceutical Company Limited
Key Topics Covered:
I. METHODOLOGY
II. EXECUTIVE SUMMARY
- Influencer Market Insights
- World Market Trajectories
- Impact of Covid-19 and a Looming Global Recession
- World Current & Future Analysis for Alpha-1 Antitrypsin Drugs by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 and % CAGR
- World Historic Review for Alpha-1 Antitrypsin Drugs by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 and % CAGR
- World 15-Year Perspective for Alpha-1 Antitrypsin Drugs by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027
III. MARKET ANALYSIS
IV. COMPETITION
- Total Companies Profiled: 43
For more information about this report visit https://www.researchandmarkets.com/r/ydf33k
Contacts
ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
